293 related articles for article (PubMed ID: 28721895)
1. Late Cardiac Toxicity After Mediastinal Radiation Therapy for Hodgkin Lymphoma: Contributions of Coronary Artery and Whole Heart Dose-Volume Variables to Risk Prediction.
Hahn E; Jiang H; Ng A; Bashir S; Ahmed S; Tsang R; Sun A; Gospodarowicz M; Hodgson D
Int J Radiat Oncol Biol Phys; 2017 Aug; 98(5):1116-1123. PubMed ID: 28721895
[TBL] [Abstract][Full Text] [Related]
2. Is mean heart dose a relevant surrogate parameter of left ventricle and coronary arteries exposure during breast cancer radiotherapy: a dosimetric evaluation based on individually-determined radiation dose (BACCARAT study).
Jacob S; Camilleri J; Derreumaux S; Walker V; Lairez O; Lapeyre M; Bruguière E; Pathak A; Bernier MO; Laurier D; Ferrieres J; Gallocher O; Latorzeff I; Pinel B; Franck D; Chevelle C; Jimenez G; Broggio D
Radiat Oncol; 2019 Feb; 14(1):29. PubMed ID: 30732640
[TBL] [Abstract][Full Text] [Related]
3. Individualized 3D reconstruction of normal tissue dose for patients with long-term follow-up: a step toward understanding dose risk for late toxicity.
Ng A; Brock KK; Sharpe MB; Moseley JL; Craig T; Hodgson DC
Int J Radiat Oncol Biol Phys; 2012 Nov; 84(4):e557-63. PubMed ID: 22929861
[TBL] [Abstract][Full Text] [Related]
4. Cardiotoxicity model-based patient selection for Hodgkin lymphoma proton therapy.
Loap P; Orlandi E; De Marzi L; Vitolo V; Barcellini A; Iannalfi A; Dendale R; Kirova Y; Mirandola A
Acta Oncol; 2022 Aug; 61(8):979-986. PubMed ID: 35668710
[TBL] [Abstract][Full Text] [Related]
5. 3-D reconstruction of anterior mantle-field techniques in Hodgkin's disease survivors: doses to cardiac structures.
Vordermark D; Seufert I; Schwab F; Kölbl O; Kung M; Angermann C; Flentje M
Radiat Oncol; 2006 Apr; 1():10. PubMed ID: 16722610
[TBL] [Abstract][Full Text] [Related]
6. Does mean heart dose sufficiently reflect coronary artery exposure in left-sided breast cancer radiotherapy? : Influence of respiratory gating.
Becker-Schiebe M; Stockhammer M; Hoffmann W; Wetzel F; Franz H
Strahlenther Onkol; 2016 Sep; 192(9):624-31. PubMed ID: 27389036
[TBL] [Abstract][Full Text] [Related]
7. Comparison of heart and coronary artery doses associated with intensity-modulated radiotherapy versus three-dimensional conformal radiotherapy for distal esophageal cancer.
Kole TP; Aghayere O; Kwah J; Yorke ED; Goodman KA
Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):1580-6. PubMed ID: 22284687
[TBL] [Abstract][Full Text] [Related]
8. Radiotherapy for early mediastinal Hodgkin lymphoma according to the German Hodgkin Study Group (GHSG): the roles of intensity-modulated radiotherapy and involved-node radiotherapy.
Koeck J; Abo-Madyan Y; Lohr F; Stieler F; Kriz J; Mueller RP; Wenz F; Eich HT
Int J Radiat Oncol Biol Phys; 2012 May; 83(1):268-76. PubMed ID: 22079733
[TBL] [Abstract][Full Text] [Related]
9. Doses to the right coronary artery and the left anterior descending coronary artery and death from ischemic heart disease after breast cancer radiotherapy: a case-control study in a population-based cohort.
Perman M; Johansson KA; Holmberg E; Karlsson P
Acta Oncol; 2024 Apr; 63():240-247. PubMed ID: 38682458
[TBL] [Abstract][Full Text] [Related]
10. Effective dose reduction to cardiac structures using protons compared with 3DCRT and IMRT in mediastinal Hodgkin lymphoma.
Hoppe BS; Flampouri S; Su Z; Latif N; Dang NH; Lynch J; Joyce M; Sandler E; Li Z; Mendenhall NP
Int J Radiat Oncol Biol Phys; 2012 Oct; 84(2):449-55. PubMed ID: 22386373
[TBL] [Abstract][Full Text] [Related]
11. The Importance of Radiation Dose to the Atherosclerotic Plaque in the Left Anterior Descending Coronary Artery for Radiation-Induced Cardiac Toxicity of Breast Cancer Patients?
van den Bogaard VAB; Spoor DS; van der Schaaf A; van Dijk LV; Schuit E; Sijtsema NM; Langendijk JA; Maduro JH; Crijns APG
Int J Radiat Oncol Biol Phys; 2021 Aug; 110(5):1350-1359. PubMed ID: 33713741
[TBL] [Abstract][Full Text] [Related]
12. Dose to the Left Anterior Descending Artery Correlates With Cardiac Events After Irradiation for Breast Cancer.
Zureick AH; Grzywacz VP; Almahariq MF; Silverman BR; Vayntraub A; Chen PY; Gustafson GS; Jawad MS; Dilworth JT
Int J Radiat Oncol Biol Phys; 2022 Sep; 114(1):130-139. PubMed ID: 35483540
[TBL] [Abstract][Full Text] [Related]
13. Optimized volumetric modulated arc therapy versus 3D-CRT for early stage mediastinal Hodgkin lymphoma without axillary involvement: a comparison of second cancers and heart disease risk.
Filippi AR; Ragona R; Piva C; Scafa D; Fiandra C; Fusella M; Giglioli FR; Lohr F; Ricardi U
Int J Radiat Oncol Biol Phys; 2015 May; 92(1):161-8. PubMed ID: 25863763
[TBL] [Abstract][Full Text] [Related]
14. Dosimetric comparison to the heart and cardiac substructure in a large cohort of esophageal cancer patients treated with proton beam therapy or Intensity-modulated radiation therapy.
Shiraishi Y; Xu C; Yang J; Komaki R; Lin SH
Radiother Oncol; 2017 Oct; 125(1):48-54. PubMed ID: 28917586
[TBL] [Abstract][Full Text] [Related]
15. Reduction of cardiac and coronary artery doses in irradiation of left-sided breast cancer during inspiration breath hold : A planning study.
Schönecker S; Heinz C; Söhn M; Haimerl W; Corradini S; Pazos M; Belka C; Scheithauer H
Strahlenther Onkol; 2016 Nov; 192(11):750-758. PubMed ID: 27632341
[TBL] [Abstract][Full Text] [Related]
16. Cardiac substructures exposure in left-sided breast cancer radiotherapy: Is the mean heart dose a reliable predictor of cardiac toxicity?
Naimi Z; Moujahed R; Neji H; Yahyaoui J; Hamdoun A; Bohli M; Kochbati L
Cancer Radiother; 2021 May; 25(3):229-236. PubMed ID: 33423965
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of a new predictor of heart and left anterior descending artery dose in patients treated with adjuvant radiotherapy to the left breast.
Mendez LC; Louie AV; Moreno C; Wronski M; Warner A; Leung E; Sakuraba R; Helito JK; Rezende A; Carvalho IT; Weltman E
Radiat Oncol; 2018 Jul; 13(1):124. PubMed ID: 29973243
[TBL] [Abstract][Full Text] [Related]
18. Dosimetric benefits of intensity-modulated radiotherapy combined with the deep-inspiration breath-hold technique in patients with mediastinal Hodgkin's lymphoma.
Paumier A; Ghalibafian M; Gilmore J; Beaudre A; Blanchard P; el Nemr M; Azoury F; al Hamokles H; Lefkopoulos D; Girinsky T
Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):1522-7. PubMed ID: 21705151
[TBL] [Abstract][Full Text] [Related]
19. Early detection and prediction of cardiotoxicity after radiation therapy for breast cancer: the BACCARAT prospective cohort study.
Jacob S; Pathak A; Franck D; Latorzeff I; Jimenez G; Fondard O; Lapeyre M; Colombier D; Bruguiere E; Lairez O; Fontenel B; Milliat F; Tamarat R; Broggio D; Derreumaux S; Ducassou M; Ferrières J; Laurier D; Benderitter M; Bernier MO
Radiat Oncol; 2016 Apr; 11():54. PubMed ID: 27056179
[TBL] [Abstract][Full Text] [Related]
20. Rationale for and preliminary results of proton beam therapy for mediastinal lymphoma.
Li J; Dabaja B; Reed V; Allen PK; Cai H; Amin MV; Garcia JA; Cox JD
Int J Radiat Oncol Biol Phys; 2011 Sep; 81(1):167-74. PubMed ID: 20643518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
